Calcium signaling in Alzheimer's disease & therapies

Alzheimer's disease (AD) is the most common type of dementia and is characterized by the accumulation of amyloid (Aβ) plaques and neurofibrillary tangles in the brain. Much attention has been given to develop AD treatments based on the amyloid cascade hypothesis; however, none of these drugs ha...

Full description

Saved in:
Bibliographic Details
Published in:Biochimica et biophysica acta. Molecular cell research 2018-11, Vol.1865 (11), p.1745-1760
Main Authors: Tong, Benjamin Chun-Kit, Wu, Aston Jiaxi, Li, Min, Cheung, King-Ho
Format: Article
Language:English
Subjects:
Alzheimer's disease
Ca2+ channels
Calcium
Channelopathy
Therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Alzheimer's disease (AD) is the most common type of dementia and is characterized by the accumulation of amyloid (Aβ) plaques and neurofibrillary tangles in the brain. Much attention has been given to develop AD treatments based on the amyloid cascade hypothesis; however, none of these drugs had good efficacy at improving cognitive functions in AD patients suggesting that Aβ might not be the disease origin. Thus, there are urgent needs for the development of new therapies that target on the proximal cause of AD. Cellular calcium (Ca2+) signals regulate important facets of neuronal physiology. An increasing body of evidence suggests that age-related dysregulation of neuronal Ca2+ homeostasis may play a proximal role in the pathogenesis of AD as disrupted Ca2+ could induce synaptic deficits and promote the accumulation of Aβ plaques and neurofibrillary tangles. Given that Ca2+ disruption is ubiquitously involved in all AD pathologies, it is likely that using chemical agents or small molecules specific to Ca2+ channels or handling proteins on the plasma membrane and membranes of intracellular organelles to correct neuronal Ca2+ dysregulation could open up a new approach to AD prevention and treatment. This review summarizes current knowledge on the molecular mechanisms linking Ca2+ dysregulation with AD pathologies and discusses the possibility of correcting neuronal Ca2+ disruption as a therapeutic approach for AD. •Ca2+ dysregulation occurs prior other Alzheimer pathologies including plaques, tangles, and synaptic deficits•Ca2+ dysregulation may be the proximal cause of Alzheimer's disease•Targeting deranged Ca2+ signaling may serve as therapeutic approaches to treat AD
ISSN:0167-4889
1879-2596
DOI:10.1016/j.bbamcr.2018.07.018